老虎证券

美股详情
本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

AbCellera Biologics

3.80
+0.05001.33%
盘后：3.830.0296+0.78%16:57 EDT
成交量：195.15万
成交额：731.48万
市值：11.34亿
市盈率：-6.69
高：3.81
开：3.77
低：3.66
收：3.75
数据加载中...
总览公司新闻资讯公告
2021/04/01

重要事件披露

8-K - Current report
2021/03/30

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/03/29

重要事件披露

8-K - Current report
2021/03/02

重要事件披露

8-K - Current report
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/09

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/12/28

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2020/12/28

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/12/21

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/12/15

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2020/12/10

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2020/12/08

SEC问询函

CORRESP [Cover] - Correspondence
2020/12/08

SEC问询函

CORRESP [Cover] - Correspondence
2020/12/07

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2020/12/03

SEC问询函

CORRESP [Cover] - Correspondence
2020/11/30

SEC问询函

CORRESP [Cover] - Correspondence
2020/11/25

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2020/11/20

SEC问询函

CORRESP [Cover] - Correspondence
2020/11/20

招股说明书

S-1 - General form for registration of securities under the Securities Act of 1933